Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2002
10/24/2002WO2002083712A2 Transporters and ion channels
10/24/2002WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
10/24/2002WO2002083709A2 Kinases and phosphatases
10/24/2002WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002WO2002083667A2 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002WO2002083576A1 A process for biochemical treatment of waste water using nano materials
10/24/2002WO2002083186A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
10/24/2002WO2002083184A2 Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
10/24/2002WO2002083183A2 Stimulation of the immune system
10/24/2002WO2002083179A2 Fusion proteins
10/24/2002WO2002083080A2 Method of treating arthritis using lentiviral vectors in gene therapy
10/24/2002WO2002083076A2 Method for inhibiting atherosclerotic plaque formation
10/24/2002WO2002083075A2 Akt and regulation of ra synovial fibroblast apoptosis
10/24/2002WO2002083074A2 Methods for the treatment of hepatic disorders
10/24/2002WO2002083072A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002WO2002083069A2 Recombinant proteins of orientia tsutsugamushi
10/24/2002WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002WO2002083064A2 A method of treating cancer
10/24/2002WO2002083060A2 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
10/24/2002WO2002082986A1 Imaging of a region in a scattering medium
10/24/2002WO2002082908A1 Method of treating arthritis using lentiviral vectors in gene therapy
10/24/2002WO2002082904A2 Method of treating or retarding the development of blindness
10/24/2002WO2002082898A1 Novel endophytic fungi and methods of use
10/24/2002WO2002082889A1 A method to control the ripening of papaya fruit and confer disease resistance to papaya plants
10/24/2002WO2002067665A3 Cloning of transgenic animals comprising artificial chromosomes
10/24/2002WO2002065091A3 Pin1 as marker for abnormal cell growth
10/24/2002WO2002064746A3 Combined transductional and transcriptional targeting system for improved gene delivery
10/24/2002WO2002064015A8 Pin1 as a marker for prostate cancer
10/24/2002WO2002062995A3 Human dorsal root receptor-like g protein-coupled receptor
10/24/2002WO2002062951A3 Antisense modulation of casein kinase 2-alpha prime expression
10/24/2002WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002WO2002057226A9 68730 and 69112 protein kinase molecules and uses therefor
10/24/2002WO2002048380A3 Glycosilated cationic lipids for liposomes used in drug delivery
10/24/2002WO2002046367A3 Antisense modulation of cellular apoptosis susceptibility gene expression
10/24/2002WO2002045524A3 Prolyl endoprotease from aspergillus niger
10/24/2002WO2002042419A3 Cell culture apparatus and methods of use
10/24/2002WO2002040715A8 Molecules for disease detection and treatment
10/24/2002WO2002040038A3 M. tuberculosis chaperonin 10 and uses thereof
10/24/2002WO2002038739A3 Bacterial expression systems
10/24/2002WO2002022830A3 Transglutaminase gene products
10/24/2002WO2002022800A3 Expression cassettes and adenovirus vectors
10/24/2002WO2002022777A3 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses
10/24/2002WO2002016569A3 38618, a human alpha/beta hydrolase and uses thereof
10/24/2002WO2002010425A3 Ascorbic acid production from yeasts
10/24/2002WO2002006462A3 Methylated nucleotide regulation of upa gene expression
10/24/2002WO2002002761A3 57658, a human uridine kinase and uses thereof
10/24/2002WO2002000913A9 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2
10/24/2002WO2001096399A3 Novel interferon-induced tetraspan protein and nucleic acids encoding same
10/24/2002WO2001077375A8 Diagnosis of diseases associated with gene regulation
10/24/2002WO2001073052A3 Thermophilic polymerase iii holoenzyme
10/24/2002WO2001073038A3 Method for the biotechnological production of l-alaninol
10/24/2002WO2001071036A3 Methods of preparing amplified nucleic acid molecules
10/24/2002WO2001068911A8 Diagnosis of diseases associated with the cell cycle
10/24/2002WO2001064861A3 Phosphoribosyl pyrophosphate synthetase 1 as herbicidal target
10/24/2002WO2001062975A9 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination
10/24/2002WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof
10/24/2002WO2001061005A3 Molecules of the pyrin domain protein family and uses thereof
10/24/2002WO2001059114A9 Tumor suppressor gene, p47ing3
10/24/2002WO2001059103A9 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
10/24/2002WO2001059092A9 Methods for generating hypermutable bacteria
10/24/2002WO2001059073A9 Cytotoxic t lymphocytes activated by dendritic cell hybrids
10/24/2002WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002WO2001055298A8 Use of a nucleotide sequence for enhancing protein synthesis and expression of proteins
10/24/2002WO2001049865A9 Fermentative production of ethanol by heterologous expression of a pyruvate decarboxylase gene in bacillus sp
10/24/2002WO2001044510A3 Nucleic acid amplification and detection of mycobacterium species
10/24/2002WO1999064449A3 Cell-permeable peptide
10/24/2002WO1999050288A3 Mammalian blood loss-induced gene, kd312
10/24/2002US20020157143 Soybean plants with enhanced yields and methods for breeding for and screening of soybean plants with enhanced yields
10/24/2002US20020157142 Herbicide target genes and methods
10/24/2002US20020157140 Esr1 - a plant gene that can promote plant regeneration and transformation
10/24/2002US20020157139 Soybean transformation method
10/24/2002US20020157138 Transformation and regeneration of sunflower cotyledons
10/24/2002US20020157137 Nucleic acids that control reproductive development in plants
10/24/2002US20020157136 Plant having altered environmental stress tolerance
10/24/2002US20020157135 Selecting first codon of parent polynucleotide for replacement with synonymous codon which has higher translational efficiency in target cell than in other cell, replacing first codon with synonymous codon
10/24/2002US20020157133 Genetic functions required for gene silencing in maize
10/24/2002US20020157132 Polynucleotide that encodes a plant cysteine gamma synthase
10/24/2002US20020157131 Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
10/24/2002US20020157130 For identifying genes the enhanced expression of which results in plants having desired traits; using recombinant DNA technology
10/24/2002US20020157129 Use of male-sterile plant for avoiding dissemination of transgene of interest which is integrated into genome of plant
10/24/2002US20020157128 Removal of metals from contaminated substrates by plants
10/24/2002US20020157127 Transgene that comprises DNA encoding for epitope tagged TATA box binding protein (TBP), production of transgenic animals which express epitope-tagged TBP and use of epitope tagged TBP for isolating and affinity purifying transcription factors
10/24/2002US20020157126 Transgenic nonhuman animal whose genome contains a nucleic acid sequence comprising a truncated Activin Type II receptor gene and a muscle-specific promoter operably linked and integrated into genome of animal; increased muscle mass
10/24/2002US20020157125 Growth differentiation factor-8
10/24/2002US20020157124 Transgenic rodents and rodent cell lines expressing HIV co-receptors
10/24/2002US20020157123 Compositions and methods for treating enzyme deficiency
10/24/2002US20020157122 Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
10/24/2002US20020157121 Propagation of human hepatocytes in non-human animals
10/24/2002US20020157120 Circularly permuted fluorescent protein indicators
10/24/2002US20020157119 Identification of activated receptors and ion channels
10/24/2002US20020157118 Human neurofilament genes may be introduced into such genetically non-human animals to produce improved models of physiology of human neurofilament proteins which may be used to study human neurodegenerative disorders
10/24/2002US20020156585 Crystallization and structure determination of Staphylococcus aureus UDP-N-acetylenolpyruvylglucosamine reductase (S. aureus MurB)
10/24/2002US20020156267 High affinity, low molecular weight displacers for oligonucleotide purification
10/24/2002US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002US20020156262 Polypeptides having lysophosphatidic acid acyltransferase activity and polynucleotides encoding polypeptides having LPAAT activity
10/24/2002US20020156261 Wherein secondary structure disintegrates upon attachment of the oligonucleotide to a target nucleic acid; anticarcenogenic agents, treatment of Ewing's sarcoma
10/24/2002US20020156260 Gene encoding a polypeptide having pre-B cell growth-supporting ability
10/24/2002US20020156259 Human adenosine deaminase
10/24/2002US20020156258 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances